Is Peanut Oral Immunotherapy Too Risky? Is Peanut Oral Immunotherapy Too Risky?
A recent study found that peanut OIT was associated with increased risk for anaphylaxis and serious adverse events, but the analysis leaves out some important considerations, says Dr Brian Vickery.Medscape Allergy & Immunology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology Commentary Source Type: news
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Health | Immunotherapy | Peanuts | Study